Shangce Du

743 total citations
14 papers, 469 citations indexed

About

Shangce Du is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Shangce Du has authored 14 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Shangce Du's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Adenosine and Purinergic Signaling (2 papers) and RNA modifications and cancer (2 papers). Shangce Du is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Adenosine and Purinergic Signaling (2 papers) and RNA modifications and cancer (2 papers). Shangce Du collaborates with scholars based in China, Germany and Russia. Shangce Du's co-authors include Ji Miao, En Xu, Xiaofeng Lu, Linsen Shi, Shichao Ai, Min Feng, Jun Song, Xuefeng Xia, Xingzhou Wang and Wenxian Guan and has published in prestigious journals such as Oncogene, Molecular Biology of the Cell and Molecular Cancer.

In The Last Decade

Shangce Du

14 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shangce Du China	13	222	144	140	106	95	14	469
Kaimi Li China	12	211 1.0×	138 1.0×	132 0.9×	102 1.0×	79 0.8×	15	397
Youlin Kuang China	13	195 0.9×	116 0.8×	93 0.7×	51 0.5×	139 1.5×	35	490
Songtao Lai China	11	314 1.4×	251 1.7×	168 1.2×	90 0.8×	105 1.1×	21	645
D Chatterjee United States	9	365 1.6×	126 0.9×	109 0.8×	38 0.4×	49 0.5×	17	497
Christine M. Heske United States	11	161 0.7×	135 0.9×	85 0.6×	162 1.5×	27 0.3×	23	380
Huiyue Dong China	14	302 1.4×	60 0.4×	158 1.1×	76 0.7×	37 0.4×	20	485
Bosen You China	16	481 2.2×	99 0.7×	302 2.2×	190 1.8×	80 0.8×	30	688
Ken Kojo Japan	15	202 0.9×	167 1.2×	63 0.5×	63 0.6×	71 0.7×	30	481
Nicole Malet France	13	275 1.2×	71 0.5×	71 0.5×	34 0.3×	105 1.1×	17	507
Emily Vucic United States	6	249 1.1×	315 2.2×	104 0.7×	48 0.5×	254 2.7×	9	616

Countries citing papers authored by Shangce Du

Since Specialization

Citations

This map shows the geographic impact of Shangce Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangce Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangce Du more than expected).

Fields of papers citing papers by Shangce Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangce Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangce Du. The network helps show where Shangce Du may publish in the future.

Co-authorship network of co-authors of Shangce Du

This figure shows the co-authorship network connecting the top 25 collaborators of Shangce Du. A scholar is included among the top collaborators of Shangce Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangce Du. Shangce Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Yan, Chen Yang, Zhicheng Liu, et al.. (2022). Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy. Molecular Cancer. 21(1). 2–2. 26 indexed citations

Du, Shangce, Zhi Yang, Xiaofeng Lu, et al.. (2021). Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling. Oncogene. 40(38). 5764–5779. 64 indexed citations

Wang, Xingzhou, Xuefeng Xia, En Xu, et al.. (2021). Estrogen Receptor Beta Prevents Signet Ring Cell Gastric Carcinoma Progression in Young Patients by Inhibiting Pseudopodia Formation via the mTOR–Arpc1b/EVL Signaling Pathway. Frontiers in Cell and Developmental Biology. 8. 592919–592919. 14 indexed citations

Xu, En, Xuefeng Xia, Zijian Li, et al.. (2020). GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT–Mediated EMT. Frontiers in Cell and Developmental Biology. 8. 591239–591239. 38 indexed citations

Xu, En, Hao Zhu, Feng Wang, et al.. (2020). OSI-027 Alleviates Oxaliplatin Chemoresistance in Gastric Cancer Cells by Suppressing P-gp Induction. Current Molecular Medicine. 21(10). 922–930. 14 indexed citations

Shi, Linsen, Ji Miao, Shangce Du, et al.. (2019). Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K–AKT–mTOR signaling. Molecular Biology of the Cell. 30(19). 2527–2534. 60 indexed citations

Du, Shangce, Ji Miao, Xiaofeng Lu, et al.. (2019). NADPH oxidase 4 is correlated with gastric cancer progression and predicts a poor prognosis.. PubMed. 11(6). 3518–3530. 14 indexed citations

Shi, Linsen, Min Feng, Shangce Du, et al.. (2019). Adenosine Generated by Regulatory T Cells Induces CD8⁺T Cell Exhaustion in Gastric Cancer through A2aR Pathway. BioMed Research International. 2019. 1–10. 58 indexed citations

Ai, Shichao, Feng Sun, Zhijian Liu, et al.. (2019). Change in serum albumin level predicts short‐term complications in patients with normal preoperative serum albumin after gastrectomy of gastric cancer. ANZ Journal of Surgery. 89(7-8). E297–E301. 12 indexed citations

10.

Du, Shangce, Kai Yin, Shichao Ai, et al.. (2018). Knockdown long noncoding RNA nuclear paraspeckle assembly transcript 1 suppresses colorectal cancer through modulating miR‐193a‐3p/KRAS. Cancer Medicine. 8(1). 261–275. 25 indexed citations

11.

Du, Shangce, Ji Miao, En Xu, et al.. (2018). NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR. Cell Death and Disease. 9(10). 948–948. 57 indexed citations

12.

Cao, Ke, Ji Miao, Xiaofeng Lu, et al.. (2018). CCDC26 knockdown enhances resistance of gastrointestinal stromal tumor cells to imatinib by interacting with c-KIT.. PubMed. 10(1). 274–282. 16 indexed citations

13.

Sun, Feng, Xiaolong Ge, Zhijian Liu, et al.. (2017). Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer. World Journal of Surgical Oncology. 15(1). 191–191. 30 indexed citations

14.

Kang, Xing, Hao Zhu, Xiaofeng Lu, et al.. (2017). DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition. Oncotarget. 8(55). 94028–94039. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact